Professor Gino Martini
RPS Assembly PharmSci Member
Awards: FRPharmS, FRSC, FEIPG
With over 25 years’ experience as an academic and industrial pharmacist, Professor Gino Martini has extensive expertise in oncology, rare and infectious diseases, drug development and medical engineering – as well as policy development and external advocacy.
As the Chief Executive of PHTA – the University of Birmingham’s flagship life sciences research accelerator – Gino is responsible for helping growing businesses to succeed, through making connections to multidisciplinary opinion leaders and providing commercialisation support and expertise.
PHTA is a £60 million state-of-the-art accelerator located within Phase 1 of Birmingham Health Innovation Campus (BHIC), comprising over 100,000 sq ft of incubation, collaboration and training space, located at the heart of the Birmingham Health Partners research and development ecosystem. Together, PHTA and BHIC generate 10,000 jobs and contribute more than £400 million GVA to the regional economy within the next decade.
Gino joined PHTA in 2021 from the Royal Pharmaceutical Society where, as Chief Scientist, he played a pivotal role in supporting pharmacists during the COVID-19 pandemic and in particular supporting the role of pharmacists as vaccinators. He was also instrumental in highlighting the dangers of Nitrous Oxide abuse in teenagers, the banning of Dintrophenol, and the reclassification of Medicinal Cannabis.